K. Tweden

发表

Platelet interaction with pyrolytic carbon heart-valve leaflets.

S. Goodman, R. Albrecht, K. Tweden, 1996, Journal of biomedical materials research.

Silver Modification of Polyethylene Terephthalate Textiles for Antimicrobial Protection

J. D. Cameron, K. Tweden, R. Bianco, 1997, ASAIO journal.

Repopulation of dentin surfaces by periodontal ligament cells and endothelial cells. Effect of basic fibroblast growth factor.

V. Terranova, K. Tweden, D. Spadone, 1989, Journal of periodontology.

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

T. Bailey, R. Brazg, Mark P. Christiansen, 2019, Diabetes Technology & Therapeutics.

In vivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis.

J. D. Cameron, K. Tweden, B. Illingworth, 1998, The Journal of heart valve disease.

Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy

F. Kaufman, C. Irace, K. Tweden, 2021, Expert review of medical devices.

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

F. Kaufman, K. Tweden, D. Deiss, 2019, Diabetes technology & therapeutics.

Immobilization of heparin oligosaccharides onto radiofrequency plasma modified pyrolytic carbon-coated graphite.

R. Marchant, K. Kottke-Marchant, K. Tweden, 1995, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

A. Dehennis, S. Garg, T. Bailey, 2021, Diabetes technology & therapeutics.

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study

F. Kaufman, C. Irace, K. Tweden, 2020, Diabetes technology & therapeutics.

Ventriculocoronary artery bypass results using a mesh-tipped device in a porcine model.

R. Emery, K. Tweden, C. V. Van Meter, 2001, The Annals of thoracic surgery.

Neovascularization of surface demineralized dentin.

V. Terranova, K. Tweden, D. Spadone, 1989, Journal of periodontology.

Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study

C. Apovian, B. Wolfe, C. Billington, 2016, Obesity Surgery.

Platelets are deposited early post-operatively on the leaflet of a mechanical heart valve in sheep without post-operative anticoagulants or antiplatelet agents. A scanning electron microscopic observation of the pyrolytic carbon surface in a mechanical heart valve.

H. Harasaki, K. Fukamachi, K. Tweden, 1996, ASAIO journal.

PLATELETS WERE EARLY POSTOPERATIVE DEPOSITIONS ON THE LEAFLET OF A MECHANICAL HEART VALVE IN SHEEP WITHOUT POSTOPERATIVE ANTICOAGULANTS OR ANTIPLATELET AGENTS

H. Harasaki, K. Fukamachi, K. Tweden, 1996 .

Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves.

J. D. Cameron, K. Tweden, A. Razzouk, 1997, The Journal of heart valve disease.

A comparison of four endosseous dental implants: single-crystal sapphire; pyrolytic carbon; an alloy of titanium, aluminum, and vanadium; and a biologically active ceramic composite composed of calcium phosphate and magnesium aluminate spinel

K. Tweden, 1987 .

Evaluation of the Tissue Response of Organic, Metallic, Ceramic and Osteoceramic Tooth Roots

T. D. Mcgee, K. Tweden, Y. Niyo, 1998 .

CHAPTER 8 Testing of Biomaterials Modified with Bioactive Molecules : A Case Study

K. Tweden, 2001 .

SILVER COATING OF CARDIOVASCULAR TEXTILES FOR ANTIMICROBIAL PROTECTION

J. D. Cameron, K. Tweden, P. Sioshansi, 1997 .

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial

C. Apovian, B. Wolfe, S. Ikramuddin, 2016, Obesity Surgery.

Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.

James Toouli, K. Fujioka, B. Wolfe, 2014, JAMA.

Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus

J. Toouli, C. Billington, H. Zulewski, 2013, Journal of obesity.

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

C. Apovian, B. Wolfe, S. Ikramuddin, 2015, Journal of obesity.

Effects of high-frequency alternating current on axonal conduction through the vagus nerve

C. N. Honda, K. Tweden, Jonathan J Waataja, 2011, Journal of neural engineering.

Vagal Nerve Block for Improvements in Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus: Three-Year Results of the VBLOC DM2 Study

J. Toouli, C. Billington, Ommega Internationals, 2016 .

Erratum to: Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study

B. Kulseng, J. Toouli, C. Billington, 2016, Obesity Surgery.

Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

J Toouli, M. Camilleri, M. Anvari, 2008, Surgery.

Real-World Data from the First US Commercial Users of an Implantable Continuous Glucose Sensor.

Samanwoy Ghosh-Dastidar, S. Ghosh-Dastidar, F. Kaufman, 2019, Diabetes technology & therapeutics.

First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes

R. Aronson, K. Tweden, Alexander Abitbol, 2019, Diabetes, obesity & metabolism.

Human serum albumin and fibrinogen interactions with an adsorbed RGD-containing peptide.

K. Tweden, M. Olivieri, 1999, Journal of biomedical materials research.

Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device.

Michael Camilleri, James Toouli, M. Camilleri, 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Vagal Nerve Control of Appetite, Energy, Regulation, and Body Weight

K. Tweden, S. Shikora, S. Kukreja, 2018 .

Ventriculocoronary artery bypass (VCAB), a novel approach to myocardial revascularization.

J. D. Cameron, K. Tweden, E. Solien, 2000, The heart surgery forum.

Description and evaluation of a ventriculo-coronary artery bypass device that provides bi-directional coronary flow.

T. Carrel, M. Slepian, R. Emery, 2004, European Journal of Cardio-Thoracic Surgery.

46: Vagal Blocking for Obesity Control (VBLOC): Studies of pancreatic and gastric function and safety in a porcine model

M. Camilleri, M. Anvari, M. Kendrick, 2006 .

Three-Dimensional Morphology and Platelet Adhesion on Pyrolytic Carbon Heart Valve Materials

S. Goodman, R. Albrecht, K. Tweden, 1995 .

First Assessment of the Performance of an Implantable CGM System through 180 Days in a Primarily Adolescent Population with Type 1 Diabetes

R. Aronson, K. Tweden, R. Rastogi, 2018, Diabetes.

Accelerated healing of cardiovascular textiles promoted by an RGD peptide.

H Harasaki, M. Helmus, H. Harasaki, 1995, The Journal of heart valve disease.

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes†

A. Gnasso, F. Kaufman, A. Cignarelli, 2020, Diabetes, obesity & metabolism.

Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

M. Camilleri, M. Anvari, R. Mårvik, 2008, Surgery.

Comparative biophysical study of adsorbed calf serum, fetal bovine serum and mussel adhesive protein films.

K. Tweden, K. H. Rittle, R. E. Loomis, 1992, Biomaterials.